Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Nov 7;18(1):1077.
doi: 10.1186/s12885-018-4962-9.

Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial

Collaborators, Affiliations
Randomized Controlled Trial

Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial

Phyllis Butow et al. BMC Cancer. .

Abstract

Background: Health service change is difficult to achieve. One strategy to facilitate such change is the clinical pathway, a guide for clinicians containing a defined set of evidence-based interventions for a specific condition. However, optimal strategies for implementing clinical pathways are not well understood. Building on a strong evidence-base, the Psycho-Oncology Co-operative Research Group (PoCoG) in Australia developed an evidence and consensus-based clinical pathway for screening, assessing and managing cancer-related anxiety and depression (ADAPT CP) and web-based resources to support it - staff training, patient education, cognitive-behavioural therapy and a management system (ADAPT Portal). The ADAPT Portal manages patient screening and prompts staff to follow the recommendations of the ADAPT CP. This study compares the clinical and cost effectiveness of two implementation strategies (varying in resource intensiveness), designed to encourage adherence to the ADAPT CP over a 12-month period.

Methods: This cluster randomised controlled trial will recruit 12 cancer service sites, stratified by size (large versus small), and randomised at site level to a standard (Core) versus supported (Enhanced) implementation strategy. After a 3-month period of site engagement, staff training and site tailoring of the ADAPT CP and Portal, each site will "Go-live", implementing the ADAPT CP for 12 months. During the implementation phase, all eligible patients will be introduced to the ADAPT CP as routine care. Patient participants will be registered on the ADAPT Portal to complete screening for anxiety and depression. Staff will be responsible for responding to prompts to follow the ADAPT CP. The primary outcome will be adherence to the ADAPT CP. Secondary outcomes include staff attitudes to and experiences of following the ADAPT CP, using the ADAPT Portal and being exposed to ADAPT implementation strategies, collected using quantitative and qualitative methods. Data will be collected at T0 (baseline, after site engagement), T1 (6 months post Go-live) and T2 (12 months post Go-live).

Discussion: This will be the first cluster randomised trial to establish optimal levels of implementation effort and associated costs to achieve successful uptake of a clinical pathway within cancer care.

Trial registration: The study was registered prospectively with the ANZCTR on 22/3/2017. Trial ID ACTRN12617000411347.

Keywords: Anxiety and depression; Cancer; Clinical pathways; Cluster randomised controlled trial; Health services; Implementation; Psycho-oncology.

PubMed Disclaimer

Conflict of interest statement

Authors’ information

Not applicable.

Ethics approval and consent to participate

This research is being conducted in accordance with the Declaration of Helsinki and Ethical Approval for this study has been granted by Sydney Local Health District (RPAH Zone) Human Research Ethics Committee, Protocol X16-0378 HREC/16/RPAH/522. Research Participation Agreement and Governance Approvals have been obtained from individual participating institutions. Protocol amendments will be submitted to to the HREC as required throughout the duration of the study.

Cancer service staff at participating cancer services will be give their consent when invited to complete surveys and participate in interviews. Patients at each site participate in the ADAPT CP as part of routine care (which they are offered and can refuse). Patients provide informed consent to collection of health service usage data from the Medical and Pharmaceutical Benefit Schemes in Australia by the research team.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Similar articles

Cited by

References

    1. Welfare, AIoHa . Cat. no. AUS 199. Canberra: AIHW; 2016. Australia’s health 2016. Australia’s health series no. 15.
    1. AIHW . Cat. no. AUS 122. Canberra: AIHW; 2010. Australia’s health 2010. Australia’s health no. 12.
    1. Mitchell AJ, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–174. doi: 10.1016/S1470-2045(11)70002-X. - DOI - PubMed
    1. Fallowfield L, et al. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001;84(8):1011. doi: 10.1054/bjoc.2001.1724. - DOI - PMC - PubMed
    1. Sanson-Fisher R, et al. The unmet supportive care needs of patients with cancer. Cancer. 2000;88(1):226–237. doi: 10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>3.0.CO;2-P. - DOI - PubMed

Publication types